Manufacturing

Orca

Pharma

Orca Bio takes commercial leap with FDA approval for Tregzi

Orca Bio is charging the WAC of $428,000 for Tregzi, a novel regulatory T cell-based therapy for blood cancer patients requiring transplants.

Angus Liu Jul 1, 2026 12:14am

FDA

Lilly, Regeneron among 7 chosen for FDA PreCheck Pilot Program

Jun 30, 2026 9:57am

red light stop light street traffic signal

Unicycive approval filing turned away by FDA again

Jun 30, 2026 9:03am

FDA stop sign

FDA snubs Sobi’s gout drug over manufacturing issues

Jun 29, 2026 11:04am

FDA

FDA issues Form 483 to Dr. Reddy's plant in India

Jun 26, 2026 11:40am

Four large while puzzle pieces are being connected together on a dark brown table by four sets of hands

Merck KGaA charts biggest deal in 10+ years with Bio-Techne buy

Jun 25, 2026 9:56am